Curcumin, Harmine, and Isovanillin Therapy for Cancer Stem Cells
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cancer treatments, particularly chemotherapy, suffer from significant side effects and are ineffective against cancer stem cells, leading to recurrence and drug resistance, while adverse drug interactions pose a global health risk.
Innovation Solution
A combination of curcumin, harmine, and isovanillin components in chemotherapeutics targets a broad spectrum of cancers with minimal side effects, effectively inducing cancer cell death and inhibiting migration and invasion.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional chemotherapy is used to treat cancer, then cancer cells are killed, but significant side effects occur and cancer stem cells are not effectively targeted leading to recurrence
Solution Approach 1:
The patent combines curcumin, harmine, and isovanillin into a composite chemotherapeutic formulation. This composite approach leverages the synergistic effects of multiple natural compounds to enhance anti-cancer activity while reducing individual compound dosages and associated side effects. The combination targets multiple pathways simultaneously, improving overall treatment efficacy and reducing recurrence through cancer stem cell elimination.
2Productivity
If conventional chemotherapy is used to treat cancer, then tumor growth is inhibited, but adverse drug interactions pose global health risks
Solution Approach 1:
The patent utilizes naturally occurring compounds (curcumin, harmine, isovanillin) that can be derived from plant sources, replacing complex synthetic chemotherapeutic agents. These natural compounds generally have better safety profiles and fewer adverse drug interactions, while maintaining effective anti-cancer activity. The formulation leverages the body's existing metabolic pathways to process these compounds, reducing the risk of harmful interactions.
3Reliability
If conventional chemotherapy is used, then cancer cells are targeted, but the treatment is ineffective against cancer stem cells leading to drug resistance
Solution Approach 1:
The composite formulation of curcumin, harmine, and isovanillin exhibits multi-functional anti-cancer mechanisms. Curcumin induces apoptosis and inhibits proliferation, harmine targets cancer stem cells and prevents self-renewal, and isovanillin enhances sensitivity to treatment. This multi-functional approach ensures both differentiated cancer cells and stem cells are effectively targeted, preventing drug resistance and recurrence through comprehensive pathway inhibition.
Data Source
AI summary
Human therapeutic treatment compositions comprising a curcumin component, a harmine component, and an isovanillin component, preferably all three in combination. The agents are synergistically effective for treatment of human conditions, especially human cancers, such as pancreatic cancers.